T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma Patients

Clinical trial NCT00057382 · TERMINATED

Trial details

NCT number: NCT00057382
Sponsor: Tularik
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2003-03-01
Enrollment: 750

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.